- Home
- HMY vs RGEN Comparison
HMY vs RGEN Comparison
Compare HMY & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMY
- RGEN
- Stock Information
- Founded
- HMY 1950
- RGEN 1981
- Country
- HMY South Africa
- RGEN United States
- Employees
- HMY N/A
- RGEN N/A
- Industry
- HMY Precious Metals
- RGEN Medical/Dental Instruments
- Sector
- HMY Basic Materials
- RGEN Health Care
- Exchange
- HMY Nasdaq
- RGEN Nasdaq
- Market Cap
- HMY 7.5B
- RGEN 8.0B
- IPO Year
- HMY N/A
- RGEN N/A
- Fundamental
- Price
- HMY $14.27
- RGEN $133.92
- Analyst Decision
- HMY Sell
- RGEN Buy
- Analyst Count
- HMY 2
- RGEN 12
- Target Price
- HMY $6.60
- RGEN $172.67
- AVG Volume (30 Days)
- HMY 5.9M
- RGEN 863.9K
- Earning Date
- HMY 01-01-0001
- RGEN 04-29-2025
- Dividend Yield
- HMY 1.05%
- RGEN N/A
- EPS Growth
- HMY 16.30
- RGEN N/A
- EPS
- HMY 0.88
- RGEN N/A
- Revenue
- HMY $3,553,951,394.00
- RGEN $650,429,000.00
- Revenue This Year
- HMY $23.09
- RGEN $13.93
- Revenue Next Year
- HMY $12.83
- RGEN $14.35
- P/E Ratio
- HMY $16.05
- RGEN N/A
- Revenue Growth
- HMY 16.84
- RGEN 4.88
- 52 Week Low
- HMY $7.97
- RGEN $102.97
- 52 Week High
- HMY $18.77
- RGEN $182.52
- Technical
- Relative Strength Index (RSI)
- HMY 42.44
- RGEN 49.67
- Support Level
- HMY $14.69
- RGEN $123.10
- Resistance Level
- HMY $16.54
- RGEN $134.06
- Average True Range (ATR)
- HMY 0.46
- RGEN 6.69
- MACD
- HMY -0.32
- RGEN -0.51
- Stochastic Oscillator
- HMY 1.66
- RGEN 41.99
About HMY Harmony Gold Mining Company Limited
Harmony Gold Mining Co Ltd is a gold mining and exploration company having operations in South Africa and Papua New Guinea (PNG). Its projects include Bambanani, Joel, Masimong, Phakisa, Target 1, Tshepong, Unisel, Doornkop, and Kusasalethu. The group's segments are Tshepong Operations, Bambanani, Joel, Doornkop, Moab Khotsong, Hidden Valley, Target 1, Kusasalethu, Masimong, Unisel, and all other surface operations.
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.